Klaus Geissler, Eva Jäger, Agnes Barna, Thamer Sliwa, Paul Knöbl, Ilse Schwarzinger, Heinz Gisslinger and Peter Valent (2016) “Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?”, Haematologica. Pavia, Italy, 101(12), pp. e492-e492. doi: 10.3324/haematol.2016.156448.